Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO  
4.15
-0.55 (-11.70%)
Other Pre-Announcement

Aziyo Biologics Posts Q3 Loss Per Share Of $0.81

Published: 11/09/2021 21:58 GMT
Aziyo Biologics Inc - Ordinary Shares - Class A (AZYO) - Aziyo Biologics Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.81.
Sees FY Sales Up 10 to 12.5 Percent.
Sees FY Sales $47 Million to $48 Million.
Q3 Sales $11.5 Million.
Q3 Earnings per Share View $-0.62, Revenue View $11.5 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $48.7 Million -- Refinitiv Ibes Data (analyst estimates).